Cover Image

OP 2.1 CCR5 in HIV Prevention and Cure

Saved in:

Bibliographic Details
Main Authors:	Helen L. Wu (Author), Gabriela M. Webb (Author), Jonah B. Sacha (Author)
Format:	Book
Published:	Elsevier, 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

OP 6.3 - 00150 Delivery and long-term expression of CCR5-blocking monoclonal antibody Leronlimab with AAV for ART-free remission from SHIV viremia
by: G. Webb, et al.
Published: (2022)

FcRn-enhancing mutations lead to increased and prolonged levels of the HIV CCR5-blocking monoclonal antibody leronlimab in the fetuses and newborns of pregnant rhesus macaques
by: Joanna Zikos, et al.
Published: (2024)

OP 6.2 - 00195 Targeted genome engineering of human t cells in vivo for HIV cure
by: P. Kumar, et al.
Published: (2022)

CCR5 Disruption in Induced Pluripotent Stem Cells Using CRISPR/Cas9 Provides Selective Resistance of Immune Cells to CCR5-tropic HIV-1 Virus
by: HyunJun Kang, et al.
Published: (2015)

OP 6.4 - 00096 High-efficiency CRISPR/Cas9-mediated disruption of ccr5 in human hematopoietic stem progenitor cells generates HIV-refractory immune systems
by: D. Claiborne, et al.
Published: (2022)

Gene editing CCR5 in HIV subjects CD4 T cells
by: D. Ando
Published: (2015)

Association of TGFβ1, TNFα, CCR2 and CCR5 gene polymorphisms in type-2 diabetes and renal insufficiency among Asian Indians
by: Gupta Arvind, et al.
Published: (2007)

OP 6.1 It's a mountain not a hill: Progress made in realizing AAV-delivered inhibitors for an HIV cure
by: Matthew R. Gardner
Published: (2022)

Potent anti-Toxoplasma gondii activity of 4-chlorophenylthioacetone-derived thiosemicarbazones: Involvement of CCR2 and CCR5 receptors and 5-lipoxygenase in the mode of action
by: Rayane Aparecida Nonato Rabelo, et al.
Published: (2023)

The transcriptional program governed by RORγt favors HIV-1 replication in CCR4+CCR6+ Th17 cells
by: V.S. Wacleche, et al.
Published: (2015)

RNAi-Mediated CCR5 Knockdown Provides HIV-1 Resistance to Memory T Cells in Humanized BLT Mice
by: Saki Shimizu, et al.
Published: (2015)

OP 1.1 Sequencing HIV: Significance and Impact
by: S. Palmer
Published: (2022)

OP 5.2 - 00070 Characterization of a dual PTPN1/PTPN2 inhibitor to target latent HIV reservoirs
by: A. Bosque, et al.
Published: (2022)

Association study between CCR2-CCR5 genes polymorphisms and chronic Chagas heart disease in Wichi and in admixed populations from Argentina.
by: Natalia Anahí Juiz, et al.
Published: (2019)

Efficient Modification of the CCR5 Locus in Primary Human T Cells With megaTAL Nuclease Establishes HIV-1 Resistance
by: Guillermo S Romano Ibarra, et al.
Published: (2016)

OP 2.5 - 00048 Targeting the SIV reservoir with Alemtuzumab
by: B. Varco-Merth, et al.
Published: (2022)

OP 3.1 HIV Persistence in women, an update
by: N. Archin
Published: (2022)

PP 4.21 - 00050 Seeding of long-lived HIV cellular reservoirs through differentiation of infected CCR5+CD4+ T cells into central memory cells
by: H. Gao, et al.
Published: (2022)

Implicación del alelo CCR5-Δ32 en la progresión clínica de pacientes VIH-1+ en Yucatán, México CCR5-Δ32 allele involvement in the clinical evolution of HIV1+ patients in Yucatán, Mexico
by: Nina Valadez-González, et al.
Published: (2011)

OP 7.4 - 00012 Series of Jojo. A way to disseminate HIV Cure information in a community language
by: J. Nabukenya
Published: (2022)

Prevalence of CCR5delta32 in Northeastern Iran
by: Amir Tajbakhsh, et al.
Published: (2019)

B cells mediate R5-Tropic HIV infection of CCR5neg naive CD4 T cells
by: A. Gerberick, et al.
Published: (2019)

oxLDL Downregulates the Dendritic Cell Homing Factors CCR7 and CCL21
by: Thomas Nickel, et al.
Published: (2012)

OP 3.5 - 00152 HIV-1RNA+infected CD4 T cell burden in acute HIV-1 infection and association with inflammatory markers
by: D. Bolton, et al.
Published: (2022)

Effect of <it>TNF-α </it>genetic variants and <it>CCR5</it>Δ<it>32 </it>on the vulnerability to HIV-1 infection and disease progression in Caucasian Spaniards
by: Peraire Joaquim, et al.
Published: (2010)

OP 5.4 - 00127 Identification and characterization of novel inhibitors of HIV Tat protein
by: S. Mediouni Jablonski, et al.
Published: (2022)

OP 3.2 - 00056 Clonally expanded HIV-1 proviruses with 5'-Leader defects can give rise to nonsuppressible residual viremia and complicate ART management
by: F. Wu, et al.
Published: (2022)

Erratum to "Potent anti-Toxoplasma gondii activity of 4-chlorophenylthioacetone-derived thiosemicarbazones: Involvement of CCR2 and CCR5 receptors and 5-lipoxygenase in the mode of action" [Med. Drug Discovery 18 (2023) 100157]
by: Rayane Aparecida Nonato Rabelo, et al.
Published: (2024)

OP 1.5 - 00046 P400/Tip60 chromatin remodeling complex in HIV transcription and latency establishment
by: L. Mori, et al.
Published: (2022)

CCR5 is a novel target for the treatment of experimental alopecia areata
by: Taisuke Ito, et al.
Published: (2020)

Levels of SAMHD1 and natural ribonucleotides may alter anti-HIV potency of antiretroviral agents in primary CD4+ CCR5+ placental macrophages
by: C. Gavegnano, et al.
Published: (2015)

Alveolar macrophages lack CCR2 expression and do not migrate to CCL2
by: Hunter Melissa G, et al.
Published: (2007)

Upregulation of expression of the chemokine receptor CCR5 by hydrogen peroxide in human monocytes
by: Geneviève Lehoux, et al.
Published: (2003)

CCR5 Gene Editing of Resting CD4+ T Cells by Transient ZFN Expression From HIV Envelope Pseudotyped Nonintegrating Lentivirus Confers HIV-1 Resistance in Humanized Mice
by: Guohua Yi, et al.
Published: (2014)

Development of Lentiviral Vectors Simultaneously Expressing Multiple siRNAs Against CCR5, vif and tat/rev Genes for an HIV-1 Gene Therapy Approach
by: Francesca Spanevello, et al.
Published: (2016)

OP 8.5 - 00104 TGF-beta Blockade to Stop HIV White Noise: a New "Release and Kill" HIV Strategy
by: E. Martinelli, et al.
Published: (2022)

OA4-2 HIV persists in colon and blood CCR6+CD4+ T cells during ART
by: A. Gosselin, et al.
Published: (2016)

How will eventual HIV cure impact prevention behavior?
by: M. Magnus, et al.
Published: (2019)

The 21st Century Cures Act: can the regulatory framework survive the "cures"?
by: Claudia Garcia Serpa Osorio-, et al.
Published: (2015)

In vitro pharmacoregulation of CC chemokine ligand 5 and its receptor CCR5 in diffuse lung diseases
by: Veronika Sekerova, et al.
Published: (2003)